Trial
NCT00115336
Ketorolac Versus Ibuprofen to Treat Painful Episodes of Sickle Cell Disease
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); University of Texas Southwestern Medical Center
Condition
Hematologic Diseases
Intervention
Intravenous Ketorolac
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-10-08